Send to

Choose Destination
Clin Radiol. 2008 Nov;63(11):1213-27. doi: 10.1016/j.crad.2008.03.014. Epub 2008 Sep 14.

Dual time point FDG-PET/CT imaging... Potential tool for diagnosis of breast cancer.

Author information

Radiology Department, Faculty of Medicine, Menoufiya University School of Medicine, Egypt.



This prospective study was designed to assess the utility of the dual time point imaging technique using 2-[(18)F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) to detect primary breast cancer and to determine whether it is useful for the detection of small and non-invasive cancers, as well as cancers in dense breast tissue.


One hundred and eleven patients with newly diagnosed breast cancer underwent two sequential PET/CT examinations (dual time point imaging) for preoperative staging. The maximum standardized uptake value (SUVmax) of FDG was measured from both time points. The percentage change in SUVmax (DeltaSUVmax%) between time points 1 (SUVmax1) and 2 (SUVmax2) was calculated. The patients were divided into groups: invasive (n=82), non invasive (n=29); large (>10mm; n=80), small (<or=10mm; n=31); tumours in dense breasts (n=61), and tumours in non-dense breasts (n=50). The tumour:background (T:B) ratios at both time points were measured and the DeltaSUVmax%, DeltaT:B% values were calculated. All PET study results were correlated with the histopathology results.


Of the 111 cancer lesions, 88 (79.3%) showed an increase and 23 (20.7%) showed either no change [10 (9%)] or a decrease [13 (11.7%)] in the SUVmax over time. Of the 111 contralateral normal breasts, nine (8.1%) showed an increase and 102 (91.9%) showed either no change [17 (15.3%)] or a decrease [85 (76.6%)] in the SUVmax over time. The mean+/-SD of SUVmax1, SUVmax2, Delta%SUVmax were 4.9+/-3.6, 6.0+/-4.5, and 22.6+/-13.1% for invasive cancers, 4.1+/-3.8, 4.4+/-4.8, and -2.4+/-18.5% for non-invasive cancers, 2.3+/-1.9, 2.7+/-2.3, and 12.9+/-21.1% for small cancers, 5.6+/-3.7, 6.8+/-4.8, and 17.3+/-17.1% for large cancers, 4.9+/-3.7, 5.8+/-4.8, and 15.1+/-17.6% for cancers in dense breast, and 4.5+/-3.6, 5.4+/-4.5, and 17.2+/-19.2% for cancers in non-dense breast. The receiver-operating characteristic (ROC) analysis suggested DeltaSUVmax% of 8% as the only significant cut-off for discrimination between invasive and non-invasive cancer (sensitivity 84.1%, specificity 75.9%, p<0.0001).


Dual time point FDG-PET/CT improves the discrimination between non-invasive and invasive cancers, and provided superior sensitivity for the detection of small cancers and cancers in dense breast.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center